These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2076034)
1. In vitro and in vivo susceptibility of Plasmodium falciparum isolates from Liberia to pyrimethamine, cycloguanil and chlorcycloguanil. Petersen E; Hogh B; Hanson AP; Bjorkman A; Flacks H Ann Trop Med Parasitol; 1990 Dec; 84(6):563-71. PubMed ID: 2076034 [TBL] [Abstract][Full Text] [Related]
2. Double-blind study to assess the efficacy of chlorproguanil given alone or in combination with chloroquine for malaria chemoprophylaxis in an area with Plasmodium falciparum resistance to chloroquine, pyrimethamine and cycloguanil. Coosemans MH; Barutwanayo M; Onori E; Otoul C; Gryseels B; Wéry M Trans R Soc Trop Med Hyg; 1987; 81(1):151-6. PubMed ID: 3328329 [TBL] [Abstract][Full Text] [Related]
3. In vitro sensitivity of Plasmodium falciparum to chlorcycloguanil in The Gambia. Panton LJ; Greenwood BM Trans R Soc Trop Med Hyg; 1985; 79(4):491-2. PubMed ID: 3909555 [TBL] [Abstract][Full Text] [Related]
4. Unexpected selections of Plasmodium falciparum polymorphisms in previously treatment-naïve areas after monthly presumptive administration of three different anti-malarial drugs in Liberia 1976-78. Jovel IT; Björkman A; Roper C; Mårtensson A; Ursing J Malar J; 2017 Mar; 16(1):113. PubMed ID: 28288632 [TBL] [Abstract][Full Text] [Related]
5. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania. Mutabingwa T; Nzila A; Mberu E; Nduati E; Winstanley P; Hills E; Watkins W Lancet; 2001 Oct; 358(9289):1218-23. PubMed ID: 11675058 [TBL] [Abstract][Full Text] [Related]
7. Monthly antimalarial chemotherapy to children in a holoendemic area of Liberia. Björkman A; Brohult J; Pehrson PO; Willcox M; Rombo L; Hedman P; Kollie E; Alestig K; Hanson A; Bengtsson E Ann Trop Med Parasitol; 1986 Apr; 80(2):155-67. PubMed ID: 3530156 [TBL] [Abstract][Full Text] [Related]
8. A comparative study of Lapudrine (chlorproguanil) and Maloprim (pyrimethamine and dapsone) as chemoprophylactics against malaria in Gambian children. Greenwood BM; Greenwood AM; Smith AW; Menon A; Bradley AK; Snow RW; Sisay F; Bennett S; Watkins WM; N'Jie AB Trans R Soc Trop Med Hyg; 1989; 83(2):182-8. PubMed ID: 2692227 [TBL] [Abstract][Full Text] [Related]
9. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil. Basco LK; Ringwald P Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484 [TBL] [Abstract][Full Text] [Related]
10. Concomitant resistance to pyrimethamine and cycloguanil of chloroquine-resistant falciparum malaria from East Africa: an in vitro study of 12 isolates. Schapira A Trans R Soc Trop Med Hyg; 1984; 78(3):359-62. PubMed ID: 6380024 [TBL] [Abstract][Full Text] [Related]
11. The chemotherapy of rodent malaria. LXII. Drug combinations to impede the selection of drug resistance, part 5: rates of development of resistance to some inhibitors of folate metabolism and to artesunate. Stewart LB; Peters W; Robinson BL Ann Trop Med Parasitol; 2004 Dec; 98(8):763-83. PubMed ID: 15667710 [TBL] [Abstract][Full Text] [Related]
12. In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum. Basco LK; Ramiliarisoa O; Le Bras J Am J Trop Med Hyg; 1994 Feb; 50(2):193-9. PubMed ID: 8116812 [TBL] [Abstract][Full Text] [Related]
13. The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodium falciparum in vitro. Watkins WM; Sixsmith DG; Chulay JD Ann Trop Med Parasitol; 1984 Jun; 78(3):273-8. PubMed ID: 6385887 [TBL] [Abstract][Full Text] [Related]
14. Activity of dihydrofolate reductase inhibitors on the hepatic stages of Plasmodium yoelii yoelii in vitro. Eriksson B; Courtier B; Bjŏrkman A; Miltgen F; Mazier D Trans R Soc Trop Med Hyg; 1991; 85(6):725-6. PubMed ID: 1801335 [TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone. Simpson JA; Hughes D; Manyando C; Bojang K; Aarons L; Winstanley P; Edwards G; Watkins WA; Ward S Br J Clin Pharmacol; 2006 Mar; 61(3):289-300. PubMed ID: 16487222 [TBL] [Abstract][Full Text] [Related]
16. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi. Alker AP; Mwapasa V; Purfield A; Rogerson SJ; Molyneux ME; Kamwendo DD; Tadesse E; Chaluluka E; Meshnick SR Antimicrob Agents Chemother; 2005 Sep; 49(9):3919-21. PubMed ID: 16127071 [TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of Plasmodium falciparum isolates from Jilore, Kenya, to antimalarial drugs. Watkins WM; Howells RE; Brandling-Bennett AD; Koech DK Am J Trop Med Hyg; 1987 Nov; 37(3):445-51. PubMed ID: 3318515 [TBL] [Abstract][Full Text] [Related]
18. [Presence of pyrimethamine and cycloguanil resistance genotype in West Africa? Evidence of a single mutation 59Arg in the dhfr gene of Plasmodium falciparum]. Pinheiro L; Rosário VE Acta Med Port; 2003; 16(4):235-8. PubMed ID: 22226208 [TBL] [Abstract][Full Text] [Related]
19. Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial. Leslie T; Mayan MI; Hasan MA; Safi MH; Klinkenberg E; Whitty CJ; Rowland M JAMA; 2007 May; 297(20):2201-9. PubMed ID: 17519409 [TBL] [Abstract][Full Text] [Related]
20. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Peterson DS; Milhous WK; Wellems TE Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3018-22. PubMed ID: 2183222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]